Related Experiment Video
Updated: Aug 23, 2026
Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
Published on: August 15, 2025
Primitive neuroectodermal tumor of the head and neck: incidence, diagnosis, and management
1Department of Otorhinolaryngology-Plastic Head and Neck Surgery, St Anna Hospital, Duisburg, Germany.
Abstract:
Primitive neuroectodermal tumors are in the Ewing's sarcoma family of tumors and are composed of small round cells. Because of their rare occurrence, optimal therapy is challenging, particularly if they occur in the head and neck. Diagnosis is based on history, immunostaining with at least 2 neural markers, ultrastructural examination, and evidence of an abnormal t(11;22)(q24;q12) translocation as the hallmark for the Ewing's sarcoma family. The prognosis in general is poor because of overt metastasis at the time of diagnosis. Of 27 reported patients with primitive neuroectodermal tumors of the head and neck, 23 were less than 20 years of age. Most patients presented with a tumor in the nasal cavity, paranasal sinuses, or neck. Symptoms developed rapidly (3.6 months, on average), and a lethal outcome occurred in 9 patients. This highly malignant tumor requires an aggressive combination of radical resection, chemotherapy, and radiotherapy. A close follow-up with regular radiographic examination for at least 5 years is mandatory.
Insights
Primitive neuroectodermal tumors (PNETs) are rare, aggressive small round cell tumors. Early diagnosis and aggressive multimodal treatment including surgery, chemotherapy, and radiotherapy are crucial for improving outcomes in head and neck PNETs.
Area of Science:
- Oncology
- Pathology
Background:
- Primitive neuroectodermal tumors (PNETs) are part of the Ewing's sarcoma family, characterized by small round cells.
- Their rarity and location in the head and neck present significant therapeutic challenges.
Observation:
- Diagnosis relies on clinical history, neural marker immunostaining, ultrastructural analysis, and the characteristic t(11;22) translocation.
- Most head and neck PNETs occur in patients under 20, often presenting in the nasal cavity, paranasal sinuses, or neck.
- Rapid symptom progression and a high rate of metastasis at diagnosis contribute to a generally poor prognosis.
Findings:
- A review of 27 head and neck PNET cases revealed a predominantly young demographic (23/27 < 20 years).
- Symptoms developed rapidly, averaging 3.6 months, with a 9/27 mortality rate.
- The aggressive nature of these tumors necessitates a comprehensive treatment approach.
Implications:
- Optimal management requires a combination of radical surgical resection, chemotherapy, and radiotherapy.
- Long-term follow-up, including regular radiographic examinations for at least 5 years, is mandatory for monitoring recurrence and metastasis.